Protective immunity and delayed type hypersensitivity reaction are uncoupled in experimental Leishmania major infection of CCR6-negative mice

Microbes and Infection

Volumn 9, Issue 3, 2007, Pages 291-299

  Lechner, Anja ^a,b   Ritter, Uwe ^a,c   Varona, Rosa ^d   Marquez, Gabriel ^d   Bogdan, Christian ^e   Körner, Heinrich ^f  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^d UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^e UNIVERSITY OF FREIBURG   (Germany)

^f School of Pharmacy and Molecular Sciences   (Australia)

Author keywords

CC chemokine receptor 6; Cell migration; Knockout; Lymphocytes; Protozoan parasite

Indexed keywords

CHEMOKINE RECEPTOR CCR6; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PARASITE ANTIGEN; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CD4+ T LYMPHOCYTE; DELAYED HYPERSENSITIVITY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL INFECTION; FLOW CYTOMETRY; IMMUNOHISTOLOGY; LEISHMANIA MAJOR; LEISHMANIASIS; LYMPH NODE CELL; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTOZOAL INFECTION; SKIN CELL;

ANIMALS; FEMALE; HYPERSENSITIVITY, DELAYED; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, CHEMOKINE;

LEISHMANIA MAJOR; MUS; PROTOZOA;

EID: 33847412010     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2006.12.002     Document Type: Article

References (47)

1. Luster A.D. Chemokines-Chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338 (1998) 436-445
2. von Andrian U.H., and Mackay C.R. T-cell function and migration. Two sides of the same coin. N. Engl. J. Med. 343 (2000) 1020-1034
3. Zlotnik A., and Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 12 (2000) 121-127
4. Bowman E.P., Campbell J.J., Soler D., Dong Z., Manlongat N., Picarella D., Hardy R.R., and Butcher E.C. Developmental switches in chemokine response profiles during B cell differentiation and maturation. J. Exp. Med. 191 (2000) 1303-1318
5. Fitzhugh D.J., Naik S., Caughman S.W., and Hwang S.T. C-C chemokine receptor 6 is essential for arrest of a subset of memory T cells on activated dermal microvascular endothelial cells under physiologic flow conditions In vitro. J. Immunol. 165 (2000) 6677-6681
6. Dieu M.C., Vanbervliet B., Vicari A., Bridon J.M., Oldham E., Ait-Yahia S., Briere F., Zlotnik A., Lebecque S., and Caux C. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 188 (1998) 373-386
7. Kucharzik T., Hudson III J.T., Waikel R.L., Martin W.D., and Williams I.R. CCR6 expression distinguishes mouse myeloid and lymphoid dendritic cell subsets: demonstration using a CCR6 EGFP knock-in mouse. Eur. J. Immunol. 32 (2002) 104-112
8. Cook D.N., Prosser D.M., Förster R., Zhang J., Kuklin N.A., Abbondanzo S.J., Niu X.D., Chen S.C., Manfra D.J., Wiekowski M.T., Sullivan L.M., Smith S.R., Greenberg H.B., Narula S.K., Lipp M., and Lira S.A. CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity 12 (2000) 495-503
9. Varona R., Villares R., Carramolino L., Goya I., Zaballos A., Gutierrez J., Torres M., Martinez A.C., and Marquez G. CCR6-deficient mice have impaired leukocyte homeostasis and altered contact hypersensitivity and delayed-type hypersensitivity responses. J. Clin. Invest. 107 (2001) 37-45
10. Baba M., Imai T., Nishimura M., Kakizaki M., Takagi S., Hieshima K., Nomiyama H., and Yoshie O. Identification of CCR6, the specific receptor for a novel lymphocyte-directed CC chemokine LARC. J. Biol. Chem. 272 (1997) 14893-14898
11. Meissner A., Zilles O., Varona R., Jozefowski K., Ritter U., Marquez G., Hallmann R., and Körner H. CC-chemokine ligand 20 partially controls adhesion of naïve B cells to activated endothelial cells under shear stress. Blood 102 (2003) 2724-2727
12. Schutyser E., Struyf S., Menten P., Lenaerts J.P., Conings R., Put W., Wuyts A., Proost P., and Van Damme J. Regulated production and molecular diversity of human liver and activation-regulated Chemokine/Macrophage inflammatory protein-3alpha from normal and transformed cells. J. Immunol. 165 (2000) 4470-4477
13. Tanaka Y., Imai T., Baba M., Ishikawa I., Uehira M., Nomiyama H., and Yoshie O. Selective expression of liver and activation-regulated chemokine (LARC) in intestinal epithelium in mice and humans. Eur. J. Immunol. 29 (1999) 633-642
14. Iwasaki A., and Kelsall B.L. Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3alpha, MIP-3beta, and secondary lymphoid organ chemokine. J. Exp. Med 191 (2000) 1381-1394
15. Kriehuber E., Breiteneder-Geleff S., Groeger M., Soleiman A., Schoppmann S.F., Stingl G., Kerjaschki D., and Maurer D. Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J. Exp. Med. 194 (2001) 797-808
16. Homey B., Dieu-Nosjean M.C., Wiesenborn A., Massacrier C., Pin J.J., Oldham E., Catron D., Buchanan M.E., Muller A., deWaal Malefyt R., Deng G., Orozco R., Ruzicka T., Lehmann P., Lebecque S., Caux C., and Zlotnik A. Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis. J. Immunol. 164 (2000) 6621-6632
17. Ambrosini E., Columba-Cabezas S., Serafini B., Muscella A., and Aloisi F. Astrocytes are the major intracerebral source of macrophage inflammatory protein-3alpha/CCL20 in relapsing experimental autoimmune encephalomyelitis and in vitro. Glia 41 (2003) 290-300
18. Bogdan C., Röllinghoff M., and Diefenbach A. The role of nitric oxide in innate immunity. Immunol. Rev. 173 (2000) 17-26
19. Launois P., Swihart K.G., Milon G., and Louis J.A. Early production of IL-4 in susceptible mice infected with Leishmania major rapidly induces IL-12 unresponsiveness. J. Immunol. 158 (1997) 3317-3324
20. Sato N., Ahuja S.K., Quinones M., Kostecki V., Reddick R., Melby P.C., Kuziel W.A., and Ahuja S.S. CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, B cell outgrowth, and sustained neutrophilic inflammation. J. Exp. Med. 192 (2000) 205-218
21. Solbach W., Forberg K., Kammerer E., Bogdan C., and Röllinghoff M. Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice. J. Immunol. 137 (1986) 702-711
22. Wilhelm P., Ritter U., Labbow S., Donhauser N., Röllinghoff M., Bogdan C., and Körner H. Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking TNF. J. Immunol. 166 (2001) 4012-4019
23. Stenger S., Thüring H., Röllinghoff M., and Bogdan C. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J. Exp. Med. 180 (1994) 783-793
24. Ritter U., Meissner A., Scheidig C., and Körner H. CD8alpha- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis. Eur. J. Immunol. 34 (2004) 1542-1550
25. Miles S.A., Conrad S.M., Alves R.G., Jeronimo S.M., and Mosser D.M. A role for IgG immune complexes during infection with the intracellular pathogen Leishmania. J. Exp. Med 201 (2005) 747-754
26. Finkelman F.D., Holmes J., Katona I.M., Urban Jr. J.F., Beckmann M.P., Park L.S., Schooley K.A., Coffman R.L., Mosmann T.R., and Paul W.E. Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol. 8 (1990) 303-333
27. van der Kwast T.H., Olthof J.G., de Ruiter H., and Benner R. Secondary delayed type hypersensitivity to sheep red blood cells in mice: dependence on long-lived memory cells. Cell. Immunol. 43 (1979) 94-102
28. Sacks D., and Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2 (2002) 845-858
29. Scharton-Kersten T., Afonso L.C., Wysocka M., Trinchieri G., and Scott P. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 154 (1995) 5320-5330
30. Mattner F., Di Padova K., and Alber G. Interleukin-12 is indispensable for protective immunity against Leishmania major. Infect. Immun. 65 (1997) 4378-4383
31. Park A.Y., Hondowicz B., Kopf M., and Scott P. The role of IL-12 in maintaining resistance to Leishmania major. J. Immunol. 168 (2002) 5771-5777
32. von Stebut E., Belkaid Y., Nguyen B.V., Cushing M., Sacks D.L., and Udey M.C. Leishmania major-infected murine langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous Leishmaniasis. Eur. J. Immunol. 30 (2000) 3498-3506
33. Diefenbach A., Schindler H., Donhauser N., Lorenz E., Laskay T., MacMicking J., Röllinghoff M., Gresser I., and Bogdan C. Type 1 interferon (IFN-α/β) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity 8 (1998) 77-87
34. Ebert L.M., and McColl S.R. Up-regulation of CCR5 and CCR6 on distinct subpopulations of antigen-activated CD4+ T lymphocytes. J. Immunol. 168 (2002) 65-72
35. Ohl L., Mohaupt M., Czeloth N., Hintzen G., Kiafard Z., Zwirner J., Blankenstein T., Henning G., and Forster R. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 21 (2004) 279-288
36. Misslitz A.C., Bonhagen K., Harbecke D., Lippuner C., Kamradt T., and Aebischer T. Two waves of antigen-containing dendritic cells in vivo in experimental Leishmania major infection. Eur. J. Immunol. 34 (2004) 715-725
37. Iezzi G., Frohlich A., Ernst B., Ampenberger F., Saeland S., Glaichenhaus N., and Kopf M. Lymph node resident rather than skin-derived dendritic cells initiate specific T-cell responses after Leishmania major infection. J Immunol 177 (2006) 1250-1256
38. Itano A.A., McSorley S.J., Reinhardt R.L., Ehst B.D., Ingulli E., Rudensky A.Y., and Jenkins M.K. Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity 19 (2003) 47-57
39. Seder R.A., and Ahmed R. Similarities and differences in CD4+ and CD8+ effector and memory T-cell generation. Nat Immunol 4 (2003) 835-842
40. Müller I. Role of T-cell subsets during the recall of immunologic memory to Leishmania major. Eur. J. Immunol. 22 (1992) 3063-3069
41. Black C.A. Delayed type hypersensitivity: current theories with an historic perspective. Dermatol. Online J. 5 (1999) 7
42. Sallusto F., Lenig D., Förster R., Lipp M., and Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401 (1999) 708-712
43. Kleinewietfeld M., Puentes F., Borsellino G., Battistini L., Rötzschke O., and Falk K. CCR6 expression defines regulatory effector/memory-like cells within the CD25(+)CD4+ T-cell subset. Blood 105 (2005) 2877-2886
44. Belkaid Y., Piccirillo C.A., Mendez S., Shevach E.M., and Sacks D.L. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420 (2002) 502-507
45. Scott P. IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J Immunol 147 (1991) 3149-3155
46. Laskay T., Diefenbach A., Röllinghoff M., and Solbach W. Early parasite containment is decisive for resistance to Leishmania major infection. Eur. J. Immunol. 25 (1995) 2220-2227
47. Laskay T., Röllinghoff M., and Solbach W. Natural killer cells participate in the early defense against Leishmania major infection. J. Immunol. 23 (1993) 2237-2241